The drug, geldanamycin, is well known for attacking a protein associated with the spread of breast cancer. However, a laboratory-based study found it also degraded a different protein that triggers blood vessel growth.
Ref : http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0048539
